The Minister of Labor, Health and Solidarity, Catherine Vautrin, announced that the government hoped to reimburse a saliva test to detect endometriosis by 2025. This test, developed by the French company Ziwig, costs around 1,000 euros and must still be validated by the High Health Authority. A new clinical study on 3000 women is underway to confirm its effectiveness.
Endometriosis is a chronic disease that affects one in ten women and causes pain and fertility problems. Its diagnosis is often late, with an average of 7 years. In January, the HAS welcomed the promising and innovative nature of the saliva test, but requested additional studies before deciding on its reimbursement. The ENDOmind association, which represents endometriosis patients, approved this initiative, but estimated that the objectives of 3,000 tests in 2024 and 10 to 20,000 tests in 2025 were insufficient. She called for the test to be accessible to all affected people, including those living in areas where medical imaging is rare.
The minister also announced awareness-raising actions among businesses and the general public on endometriosis, as well as a national communications campaign which will be launched in the coming weeks.
 Pascal Lemontel
|
07/03/2024 | 
